139
Views
66
CrossRef citations to date
0
Altmetric
Original Research

Serum Ionized Magnesium Levels in Relation to Metabolic Syndrome in Type 2 Diabetic Patients

, MD, , MD, , ChD, , MD, , MD, , MD, , MD & , MD show all
Pages 210-215 | Received 19 Feb 2005, Accepted 14 Feb 2006, Published online: 14 Jun 2013

REFERENCES

  • Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP: Prospective analysis of the insulin-resistance syndrome (syndrome X).Diabetes41 :715– 722,1992 .
  • Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome.Diabetes Care24 :683– 689,2001 .
  • Durlach J, Rayssiguier Y: Magnésium et glucides. II. Données cliniques et thérapeutiques.Magnesium2 :192– 224,1983 .
  • Resnick LM, Gupta RK, Bhargava KK, Gruenspan H, Alderman MH, Laragh JH: Cellular ions in hypertension, diabetes, and obesity: a nuclear magnetic resonance spectroscopic study.Hypertension17 :951– 957,1991 .
  • Resnick LM: Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders: mechanism of syndrome X.Am J Hypertens6 :123S– 134S,1993 .
  • Paolisso G, Barbagallo M: Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium.Am J Hypertens10 :346– 355,1997 .
  • Barbagallo M, Gupta R, Dominguez LJ, Resnick LM: Cellular ionic alterations with aging: relation to hypertension and diabetes.J Am Geriatr Soc48 :1111– 1116,2000 .
  • Kao WH, Folsom AR, Nieto FJ, Watson RL, Brancati FL: Serum and dietary magnesium and the risk for type 2 diabetes mellitus in the Atherosclerosis Risk in Community study.Arch Intern Med159 :2151– 2159,1999 .
  • Mather HM, Nisbet JA, Burton GH, Poston GJ, Bland JM, Bailey PA, Pilkington TR: Hypomagnesaemia in diabetes.Chim Clin Acta95 :235– 242,1979 .
  • Resnick LM, Altura BT, Gupta RK, Laragh JH, Alderman MH, Altura BM: Intracellular and extracellular magnesium depletion in type II (non insulin-dependent) diabetes mellitus.Diabetologia36 :767– 770,1993 .
  • Winegard AI: Does a common mechanism induce the diverse complications of diabetes?Diabetes36 :396– 406,1987 .
  • Grafton G, Bunce CM, Sheppard MC, Brown G, Baxter MA: Effect of Mg2+ on Na+-dependent inositol transport.Diabetes41 :35– 39,1992 .
  • Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, Busardò A, Paolisso G: Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X.Mol Asp Med24 :39– 52,2003 .
  • Corica F, Allegra A, Ientile R, Buemi M: Magnesium concentrations in plasma, erythrocytes, and platelets in hypertensive and normotensive obese patients.Am J Hypertens10 :1311– 1313,1997 .
  • Haenni A, Ohrvall M, Lithell H: Atherogenic lipid fractions are related to ionized magnesium status.Am J Clin Nutr67 :202– 207,1998 .
  • Guerrero-Romero F, Rodriguez-Moran M: Low serum magnesium levels and metabolic syndrome.Acta Diabetol39 :209– 213,2002 .
  • National Institutes of Health: “Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).” NIH Publication 01-3670. Bethesda: National Institutes of Health,2001 .
  • Corsonello A, Ientile R, Buemi M, Cucinotta D, Mauro VN, Macaione S, Corica F: Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria.Am J Nephrol20 :187– 192,2000 .
  • Ising H, Bertschat F, Gunther T, Jeremias E, Jeremias A: Measurement of free magnesium in blood, serum and plasma with an ion-sensitive electrode.Eur J Clin Chem Clin Biochem33 :365– 371,1995 .
  • Altura BT, Brust M, Bloom S, Barbour RL, Stempak JG, Altura BM: Magnesium dietary intake modulates blood lipid levels and atherogenesis.Proc Natl Acad Sci USA87 :1840– 1844,1990 .
  • Rasmussen HS, Aurup P, Goldstein K, McNair P, Mortensen PB, Larsen OG, Lawaetz H: Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study.Arch Intern Med149 :1050– 1053,1989 .
  • Corica F, Allegra A, Di Benedetto A, Giacobbe MS, Romano G, Cucinotta D, Buemi M, Ceruso D: Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin dependent diabetes mellitus.Magnes Res7 :43– 47,1994 .
  • De Leeuw I, Vansant G, Van Gaal L: Magnesium and obesity: influence of gender, glucose tolerance, and body fat distribution on circulating magnesium concentrations.Magnes Res5 :183– 187,1992 .
  • Laires MJ, Moreira H, Monteiro CP, Sardinha L, Limao F, Veiga L, Goncalves A, Ferreira A, Bicho M: Magnesium, insulin resistance and body composition in healthy postmenopausal women.J Am Coll Nutr23 :510S– 513S,2004 .
  • Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R: Abdominal obesity, insulin resistance, and metabolic syndrome in a southern European population.Eur J Intern Med14 :101– 106,2003 .
  • McNair P, Christensen MS, Christiansen C, Modshod S, Transbol IB: Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis.Eur J Clin Invest12 :81– 85,1982 .
  • Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus.Clin Chem48 :436– 472,2002 .
  • Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE: Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial.Diabetes Care25 :275– 278,2002 .
  • Schnack C, Bauer I, Pregant P, Hopmeier P, Schernthaner G: Hypomagnesaemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control.Diabetologia35 :77– 79,1992 .
  • Paolisso G, Sgambato S, Giugliano D, Torella R, Varricchio M, Scheen AJ, D’Onofrio F, Lefebvre PJ: Impaired insulin-induced erythrocyte magnesium accumulation is correlated to impaired insulin-mediated glucose disposal in type 2 (non-insulin-dependent) diabetic patients.Diabetologia31 :910– 915,1988 .
  • Dewitte K, Dhondt A, Giri M, Stockl D, Rottiers R, Lameire N, Thienpont LM: Differences in serum ionized and total magnesium values during chronic renal failure between nondiabetic and diabetic patients: a cross-sectional study.Diabetes Care27 :2503– 2505,2004 .
  • Liao F, Folsom AR, Brancati FL: Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study.Am Heart J136 :480– 490,1998 .
  • Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA: Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study.J Clin Epidemiol48 :927– 940,1995 .
  • Pham PC, Pham PM, Pham PA, Pham SV, Pham HV, Miller JM, Yanagawa N, Pham PT: Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2.Clin Nephrol63 :429– 436,2005 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.